AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
复制标题
DOI:
10.1186/s12882-018-1050-y
复制
发表时间:
2018-11-22
期刊:
影响因子:
2.3
通讯作者:
Nagata M
中科院分区:
文献类型:
--
作者:
Manabe S;Iwasaki C;Hatano M;Kametani F;Yazaki M;Nitta K;Nagata M
Immunoglobulin heavy-and-light-chain amyloidosis (AHL amyloidosis) is a newly established disease entity where both the immunoglobulin heavy-chain and light-chain compose amyloid fibrils. The immunoglobulins responsible for the amyloid fibrils are generally identified by immunostaining and/or laser microdissection-liquid chromatography-tandem mass spectrometry (LMD-LC-MS/MS). However, both techniques do not biochemically differentiate immunoglobulins that formed amyloid fibrils from non-responsible immunoglobulins. We herein report a case of 67-year-old female patient with renal amyloidosis due to lymphoplasmacytic lymphoma secreting monoclonal immunoglobulin M (IgM)-kappa. Renal immunostaining monotypically positive for IgM-kappa and LMD-LC-MS/MS identification of mu heavy-chain and kappa light-chain were consistent with the diagnosis of AHL amyloidosis. In order to confirm that both the immunoglobulin heavy-chain and light-chain were forming amyloid fibrils, we performed LC-MS/MS of renal amyloid fibrils isolated by the traditional amyloid purification method. The additional LC-MS/MS identified kappa light-chain only without any heavy-chain component. These results were suggestive that amyloid fibrils were composed by kappa light-chain only and that the mu heavy-chain identified by immunostaining and LMD-LC-MS/MS was derived from the non-specific co-deposition of monoclonal IgM-kappa. The case was AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition. While immunostaining and LMD-LC-MS/MS are irreplaceable techniques to classify amyloidosis, confident exclusion of the present condition should be required to diagnose AHL amyloidosis.
登录
查看更多内容
影响因子:
19.6
作者:
Nasr, Samih H.;Said, Samar M.;Leung, Nelson
通讯作者:
Leung, Nelson
影响因子:
13.2
作者:
Nasr, SH;Lobritto, SJ;Markowitz, GS
通讯作者:
Markowitz, GS
影响因子:
13.2
作者:
Manabe, Shun;Hatano, Michiyasu;Nagata, Michio
通讯作者:
Nagata, Michio
DOI:
10.2215/cjn.02890310
发表时间:
2010-12-01
影响因子:
9.8
作者:
Sethi, Sanjeev;Theis, Jason D.;Dogan, Ahmet
通讯作者:
Dogan, Ahmet
DOI:
10.1080/10245330410001671561
发表时间:
2004-04-01
期刊:
Hematology (Amsterdam, Netherlands)
影响因子:
--
作者:
Kinoshita, Koji;Yamagata, Toshiaki;Kanamaru, Akihisa
通讯作者:
Kanamaru, Akihisa